2006Journal of Pathogen BiologyRequires access

Distribution and drug resistance analysis of Escherichia coli and Klebsiella pneumoniae producing extended spectrum beta-lactamases

Yu Denggao

Open publisher page 0 citations

Abstract

Objective To investigate the distribution and drug resistance of Escherichia coli and Klebsiella pneumoniae producing extended spectrum beta-lactamases(ESBLs) in hospital.Methods ESBLs was detected by CLSI/NCCLS phenotypic confirmatory test in E.coli(n=307) and K.pneumoniae(n=202) which were isolated from July 2004 to July 2006 in the hospital.Antimicrobial susceptibility was tested by Kirby-Bauer method.The distribution and drug resistance of strains producing ESBLs was analyzed.Results The detection rate of E.coli and K.pneumoniae producing ESBLs was 38.4%(118/307) and 31.7%(64/202),respectively.The distribution of specimens mainly came from urine,sputum and respiratory secretions.The distribution of wards mainly came from pulmonary disease,neurosurgery,infectious,urology and ICU ward.The strains producing ESBLs were very susceptible to imipenem and meropenem,and relatively susceptible to piperacillin/tazobactam,cefoperazone/sulbactam and cefoxitin.The resistance rate of the strains producing ESBLs was high to other antimicrobial.Conclusion The E.coli and K.pneumoniae strains producing ESBLs distribute various kinds of specimens from different wards.Imipenem and meropenem of carbapenems could be better antimicrobial to treat the infection by strains producing ESBLs.

About this research paper

What this paper is about

Objective To investigate the distribution and drug resistance of Escherichia coli and Klebsiella pneumoniae producing extended spectrum beta-lactamases(ESBLs) in hospital.Methods ESBLs was detected by CLSI/NCCLS phenotypic confirmatory test in E.coli(n=307) and K.pneumoniae(n=202) which were isolated from July 2004 to July 2006 in the hospital.Antimicrobial susceptibility was tested by Kirby-Bauer method.The distribution and drug resistance of strains producing ESBLs was analyzed.Results The detection rate of E.coli and K.pneumoniae producing ESBLs was 38.4%(118/307) and 31.7%(64/202),respectively.The distribution of specimens mainly came from urine,sputum and respiratory secretions.The distribution of wards mainly came from pulmonary disease,neurosurgery,infectious,urology and ICU ward.The strains producing ESBLs were very susceptible to imipenem and meropenem,and relatively susceptible to piperacillin/tazobactam,cefoperazone/sulbactam and cefoxitin.The resistance rate of the strains producing ESBLs was high to other antimicrobial.Conclusion The E.coli and K.pneumoniae strains producing ESBLs distribute various kinds of specimens from different wards.Imipenem and meropenem of carbapenems could be better antimicrobial to treat the infection by strains producing ESBLs.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the distribution and drug resistance of Escherichia coli and Klebsiella pneumoniae producing extended spectrum beta-lactamases(ESBLs) in hospital.Methods ESBLs was detected by CLSI/NCCLS phenotypic confirmatory test in E.coli(n=307) and K.pneumoniae(n=202) which were isolated from July 2004 to July 2006 in the hospital.Antimicrobial susceptibility was tested by Kirby-Bauer method.The distribution and drug resistance of strains producing ESBLs was analyzed.Results The detection rate of E.coli and K.pneumoniae producing ESBLs was 38.4%(118/307) and 31.7%(64/202),respectively.The distribution of specimens mainly came from urine,sputum and respiratory secretions.The distribution of wards mainly came from pulmonary disease,neurosurgery,infectious,urology and ICU ward.The strains producing ESBLs were very susceptible to imipenem and meropenem,and relatively susceptible to piperacillin/tazobactam,cefoperazone/sulbactam and cefoxitin.The resistance rate of the strains producing ESBLs was high to other antimicrobial.Conclusion The E.coli and K.pneumoniae strains producing ESBLs distribute various kinds of specimens from different wards.Imipenem and meropenem of carbapenems could be better antimicrobial to treat the infection by strains producing ESBLs.

Key concepts: Klebsiella pneumoniae, Meropenem, Imipenem, Microbiology, Sulbactam, Tazobactam, Drug resistance, Cefoperazone

Related papers

Back to paper searchBrowse research topicsOriginal source
Distribution and drug resistance analysis of Escherichia coli and Klebsiella pneumoniae producing extended spectrum beta-lactamases — Research Paper | ScholarLens